Memantine and convulsion Patient Reports February 10, 2010

Memantine Side Effects Report #5717283-8
Memantine side effect was reported by a Consumer or non-health professional from FRANCE on Apr 07, 2008. Female patient, 90 years of age, weighting 149.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: convulsion, dehydration, dementia , diarrhoea, disease progression, epilepsy , malaise, neutrophil count increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with ARICEPT, FLECAINIDE ACETATE, VIRLIX, EQUANIL, IMOVANE. Patient recovered.

Memantine Side Effects Report #5067183-4
Memantine side effect was reported by a Health Professional from FRANCE on July 10, 2006. Male patient, 88 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: convulsion, loss of consciousness, malaise. Memantine dosage: 10 MG BID PO. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4512389-3
Memantine side effect was reported by a Health Professional from on Nov 08, 2004. Female patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood pressure increased, convulsion, loss of consciousness, transient ischaemic attack. Memantine dosage: 10 MG BID PO. During the same period patient was treated with ARICEPT, LEVOTHYROXINE, PLAVIX, FAMOTIDINE, FOSAMAX, VITAMIN E, CALCIUM. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4525756-9
Memantine side effect was reported by a Consumer or non-health professional from on July 23, 2004. Female patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: convulsion, fatigue, urinary tract infection . Memantine dosage: 5 MG QD PO. During the same period patient was treated with PREVACID, VITAMINS. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #5682201-8
Memantine side effect was reported by a Physician from UNITED STATES on Mar 13, 2008. Male patient, 82 years of age, weighting 160.3 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: body temperature decreased, bradycardia, convulsion, lethargy, loss of consciousness, mental status changes, presyncope. Memantine dosage: unknown. During the same period patient was treated with ARICEPT, DIAZEPAM. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5923541-4
Memantine side effect was reported by a Physician from UNITED STATES on Oct 08, 2008. Male patient, 82 years of age, weighting 160.3 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: asthenia, blood pressure systolic increased, body temperature decreased, bradycardia, convulsion, hyperhidrosis, lethargy, loss of consciousness, mental status changes. Memantine dosage: 28 MG (28 MG, 1 IN 1 D), ORAL. During the same period patient was treated with ARICEPT, DIAZEPAM, METAMUCIL. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5892179-X
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Sept 10, 2008. Male patient, 80 years of age, was diagnosed with dementia alzheimer's type, urinary retention and was treated with Memantine. After drug was administered, patient experienced the following side effects: apnoea, blood pressure increased, cerebral amyloid angiopathy, cerebral haemorrhage, cholinergic syndrome, convulsion, depressed level of consciousness, diarrhoea, haemorrhage subcutaneous. Memantine dosage: 20 MG (20 MG,ONCE DAILY AFTER BREAKFAST, ORAL; 20 MG (20 MG,ONCE DAILY AFTER BREAKFAST), ORAL. During the same period patient was treated with DISTIGIMINE BROMIDE, DISTIGIMINE BROMIDE, PIRENOXINE, PRANOPROFEN, NIFEDIPINE, ASPIRIN, MAGNESIUM HYDROXIDE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5054538-7
Memantine side effect was reported by a Health Professional from GERMANY on June 28, 2006. Male patient, 79 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: agitation, balance disorder, confusional state, convulsion, hallucination, insomnia, paranoia, suicidal behaviour. Memantine dosage: 10 MG BID PO. During the same period patient was treated with ARICEPT, SINEMET, CAPRIN, XATRAL. Patient recovered.

Memantine Side Effects Report #5085078-7
Memantine side effect was reported by a Consumer or non-health professional from IRELAND on Aug 02, 2006. Male patient, 79 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: agitation, balance disorder, confusional state, convulsion, hallucination, insomnia, paranoia, suicidal ideation. Memantine dosage: 10 MG BID PO. During the same period patient was treated with ARICEPT, SINEMET, CAPRIN, XATRAL. Patient recovered.


Memantine Side Effects Report #4979556-6
Memantine side effect was reported by a Health Professional from IRELAND on Apr 05, 2006. Male patient, 79 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: agitation, balance disorder, confusional state, convulsion, hallucination, insomnia, paranoia, suicidal ideation. Memantine dosage: 10 MG BID PO. During the same period patient was treated with ARICEPT, SINEMET, CAPRIN, XATRAL. Patient recovered.

Memantine Side Effects Report #5223588-X
Memantine side effect was reported by a Consumer or non-health professional from ITALY on Jan 11, 2007. Male patient, 75 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: convulsion, dysphasia, electroencephalogram abnormal, faecal incontinence, loss of consciousness, malaise, trismus. Memantine dosage: 10 MG BID PO. During the same period patient was treated with QUETIAPINE FUMARATE, QUETIAPINE FUMARATE, VALPROIC ACID. Patient recovered.

Memantine Side Effects Report #5315159-1
Memantine side effect was reported by a Health Professional from ITALY on Apr 23, 2007. Male patient, 75 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: aphasia , convulsion, electrocardiogram abnormal, electroencephalogram abnormal, faecal incontinence, loss of consciousness, major depression, malaise, speech disorder. Memantine dosage: 10 MG BID PO. During the same period patient was treated with QUETIAPINE FUMARATE, QUETIAPINE FUMARATE, VALPROIC ACID. Patient recovered.

Memantine Side Effects Report #5569751-X
Memantine side effect was reported by a Physician from UNITED STATES on Dec 10, 2007. Female patient, 75 years of age, weighting 130.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: acute prerenal failure, agitation, blood pressure decreased, body temperature increased, cardiomegaly, convulsion, dehydration, dementia , fall . Memantine dosage: 28 MG QD PO. During the same period patient was treated with LIPITOR, ALLEGRA, EXELON, PRILOSEC, CALCIUM, CENTRIUM SILVER, ASPIRIN, GLYCOLAX. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5955511-4
Memantine side effect was reported by a Pharmacist from GERMANY on Nov 05, 2008. Female patient, 73 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: cerebrovascular accident, convulsion, simple partial seizures, tremor. Memantine dosage: 10 MG (10 MG, 1 IN 1 D), ORAL. During the same period patient was treated with ARICEPT, ATENOLOL, CAPTEA, LIPANOR, STABLON. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #6084702-X
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Feb 05, 2009. Male patient, 68 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: convulsion. Memantine dosage: 5 MG (5 MG, 1 IN 1 D) ,ORAL. During the same period patient was treated with DONEPEZIL. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5874781-4
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Aug 19, 2008. Male patient, 65 years of age, weighting 125.7 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, coma, convulsion, dyskinesia, excoriation, hypophagia, infection , somnolence. Memantine dosage: 20 MG (20 MG, 1 IN 1 D), ORAL; 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with BROTIZOLAM, AMLODIPINE BESYLATE, RISPERIDONE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #6138572-1
Memantine side effect was reported by a Pharmacist from GERMANY on Mar 11, 2009. Female patient, 63 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: aggression, condition aggravated, convulsion, eructation, extrapyramidal disorder, galactorrhoea, hypothyroidism, irritability, protrusion tongue. Memantine dosage: unknown. During the same period patient was treated with DONEPEZIL, QUETIAPINE FUMARATE, TOPIRAMATE, HALOPERIDOL, PROMAZINE HYDROCHLORIDE. Patient recovered.

Memantine Side Effects Report #5156769-4
Memantine side effect was reported by a Consumer or non-health professional from SWITZERLAND on Nov 03, 2006. Female patient, 58 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: convulsion, grand mal convulsion, hypochloraemia, hypokalaemia, inappropriate antidiuretic hormone secretion, loss of consciousness. Memantine dosage: 15 MG QD PO. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #6024609-7
Memantine side effect was reported by a Pharmacist from GERMANY on Sept 25, 2008. Male patient was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: convulsion, gaze palsy. Memantine dosage: unknown. During the same period patient was treated with REMINYL. Patient recovered.


Memantine Side Effects Report #5878509-3
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Aug 26, 2008. Female patient, 94 years of age, was diagnosed with dementia  and was treated with Memantine. After drug was administered, patient experienced the following side effects: convulsion, hallucination, psychomotor hyperactivity. Memantine dosage: 20 MG (10 MG, 2 IN 1), ORAL. Patient recovered.

Memantine Side Effects Report #5878525-1
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Aug 26, 2008. Female patient, 94 years of age, was diagnosed with dementia  and was treated with Memantine. After drug was administered, patient experienced the following side effects: convulsion, hallucination, psychomotor hyperactivity. Memantine dosage: 20 MG, (10 MG, 2 IN 1 D), ORAL. Patient recovered.

Memantine Side Effects Report #5072877-0
Memantine side effect was reported by a Health Professional from GERMANY on July 12, 2006. Male patient, 82 years of age, weighting 176.4 lb, was diagnosed with dementia  and was treated with Memantine. After drug was administered, patient experienced the following side effects: convulsion, status epilepticus. Memantine dosage: 10 MG BID PO. During the same period patient was treated with OXAZEPAM, REMINYL, MELPERON, DURAZANIL, ATROVENT, TAMSULOSIN. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5811146-5
Memantine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 25, 2008. Male patient, 69 years of age, was diagnosed with dementia , emotional distress and was treated with Memantine. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, convulsion, petit mal epilepsy. Memantine dosage: 5 MG QD PO. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, CARBAMAZEPINE, LEVETIRACETAM, LORAZEPAM, OLANZAPINE, TRAZODONE. Patient died on 06/01/2008.

Memantine Side Effects Report #5650223-9
Memantine side effect was reported by a Health Professional from FRANCE on Feb 12, 2008. Male patient, 77 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: aspiration, brain scan abnormal, cerebral atrophy, coma, convulsion, depressed level of consciousness, disorientation, dyskinesia, electrocardiogram abnormal. Memantine dosage: 20 MG QD;PO. During the same period patient was treated with MIRTAZAPINE, MEPROBAMATE, MODOPAR, THEOSTAT, ZOCOR, PLAVIX. Patient was hospitalized. Patient died on 11/08/2007.


Memantine Side Effects Report #4766366-8
Memantine side effect was reported by a Pharmacist from FRANCE on Aug 26, 2005. Male patient, 71 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase decreased, c-reactive protein increased, convulsion, creatine phosphokinase decreased, creatinine renal clearance decreased, erysipelas. Memantine dosage: 10 MG BID PO. During the same period patient was treated with ARICEPT, PREVISCAN, LOVENOX, PENICILLIN G. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4785156-3
Memantine side effect was reported by a Health Professional from FRANCE on Sept 16, 2005. Male patient, 71 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase decreased, c-reactive protein increased, convulsion, creatine phosphokinase decreased, creatinine renal clearance decreased, erysipelas. Memantine dosage: 10 MG BID PO. During the same period patient was treated with ARICEPT, PREVISCAN, LOVENOX, PENICILLIN G. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4758422-5
Memantine side effect was reported by a Health Professional from UNITED KINGDOM on Aug 23, 2005. Male patient was treated with Memantine. After drug was administered, patient experienced the following side effects: convulsion. Memantine dosage: 10 MG QD PO. Patient recovered.